On the 26th, AstraZeneca Korea announced that it had signed a joint promotion agreement with Abbott Korea for the early diagnosis and treatment of patients with diabetic kidney disease.

The signing ceremony was held at AstraZeneca Korea’s headquarters in Samseong-dong, Seoul on the 25th ,in the presence of key officials from both companies, including AstraZeneca Korea’s Director Il Shim and Abbott Rapid Diagnostics’ Director Jeong-Seon Heo.

The agreement was made between AstraZeneca Korea and Abbott for their mutual cooperation in improving the treatment environment for patients with diabetic kidney disease in Korea to establish a more systemic diabetes treatment and management syste